Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00776100 · ClinicalTrials.gov registry record · Phase 2

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

A Phase 2 study, sponsored by Alliance for Clinical Trials in Oncology.

Terminated
Registry status
Phase 2
Development phase
3
Enrollment target

NCT00776100 is a Phase 2 study that was terminated before completion, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00776100, a Phase 2 study, was terminated before completion, sponsored by Alliance for Clinical Trials in Oncology.

TERMINATED
Registry status
Phase 2
Development phase
3 participants
Enrollment target

Study Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Sometimes, after chemotherapy, the tumor may not need more treatment until it progresses. In this case, observation may be sufficient. It is not yet known whether radiation therapy is more effective than observation after chemotherapy in treating non-small cell lung cancer. PURPOSE: This randomized phase II trial is studying how well radiation therapy works compared with observation after chemotherapy in treating patients with stage IV non-small cell lung cancer.

Interventions

  • RADIATION radiation therapy
  • OTHER clinical observation

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2008-10
Est. Completion 2010-09
Phase Phase 2

What the Registry Record Tells You About NCT00776100

The ClinicalTrials.gov registry entry for NCT00776100 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.

NCT00776100 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00776100 about?

NCT00776100 is a clinical study titled "Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Sometimes, after chemotherapy, the tumor may not need more treatment until it progresses. In this case, observation may be sufficient. It is not yet known whether radiation therapy is more effective than observation after chem...

What is the current status of trial NCT00776100?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2008-10. Estimated completion is 2010-09.

What interventions are being tested in trial NCT00776100?

The interventions under investigation include: radiation therapy (RADIATION), clinical observation (OTHER).

Who is sponsoring clinical trial NCT00776100?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.